Search is Powered by Google
Cancer / Oncology News

A Method To Quantify Residents' Jargon Use During Counseling Of Standardized Patients About Cancer Screening

Main Category: Cancer / Oncology
Article Date: 25 Aug 2008 - 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

UroToday.com - A report in the Journal of General Internal Medicine by Dr. Lindsay Deuster and colleagues evaluates the ability of residents to communicate with patients about cancer screening - and specifically the use of jargon language during these counseling sessions. Jargon is defined by the authors as "specialized language of a trade, profession, or similar group" that is not easily understood by others. The authors used a communication quality indicator and methods from corpus linguistics in order to quantify jargon usage.

Transcripts of conversations between internal medicine residents and standardized patients, portrayed to have a question about screening for prostate or breast cancer, were abstracted. These transcripts were made from tapes collected during four workshops in a primary care internal medicine residency program. Residents were asked to give informed consent and patients began with a short speech, patterned after an example they were given, to inquire about prostate or breast cancer screening. The final sample for analysis consisted of 86 transcripts (41 prostate cancer and 45 breast cancer). A structured 7-step protocol was used to abstract jargon word lists and evaluate transcripts for explanations of these jargon words.

Patient interviews averaged 10.1 minutes and inter-abstractor reliability was very high. Across 86 transcripts, 350 unique jargon words were identified, with an average of 19.6 unique jargon words per transcript. Most words were used more than once, for an average of 53.6 jargon words used per transcript. No difference was found in jargon word usage, either by resident gender of year in residency. On average, 4.5 explanations per transcript were found. More explanations were found in prostate cancer screening transcripts (5.9) compared to breast cancer (3.2). The average explanation ratio was 0.15, meaning that 85% of jargon was not explained. The 5 most commonly used prostate screening jargon words were prostate, screen, symptom, rectal, and biopsy. The results suggest that the use of jargon words is high in cancer screening, and the prevalence of jargon explanations are low.

Deuster L, Christopher S, Donovan J, Farrell M
J Gen Intern Med. 2008 Aug 1. Epub ahead of print.

Reported by UroToday.com Contributing Editor Christopher P. Evans, MD, FACS

UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.

To access the latest urology news releases from UroToday, go to: www.urotoday.com

Copyright © 2008 - UroToday




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Urology
ADHD Autism Diabetes

add medical news today to your facebook

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


customize your homepage


These are the most read articles from this news category for the last 6 months:
Top Article Star
Shocking Pictures To Appear On Cigarette Packets In UK On 1st October
27 Sep 2008
The UK's ten million Smokers may see pictures of rotting teeth, throat cancer, and indications of male impotence (erectile dysfunction) on cigarette packets they buy at the beginning of October...


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

View more videos...